Shame-Focused Cognitive Behavioral Therapy For Reducing Suicide Risk In Adolescent Psychiatric Inpatients (SF-CBT)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-18
SponsorPeking University
About this trial
This pilot randomized controlled trial (RCT) aims to evaluate the feasibility, acceptability, and preliminary efficacy of Shame-Focused Cognitive Behavioral Therapy (SF-CBT) among high-risk psychiatric inpatient adolescents. Shame has been identified as a critical psychological mechanism underlying suicidal ideation and behavior, yet few interventions directly target it. SF-CBT is a structured, manualized intervention designed to reduce shame, improve coping strategies, and lower suicide risk.
Approximately 42 adolescents aged 13-18 years, admitted for recent suicide attempt or severe suicidal ideation, will be randomized in a 2:1 ratio to receive either SF-CBT or supportive therapy (ST). Both conditions include 7 individual sessions for adolescents and 3 structured psychoeducation sessions for parents/guardians.
Primary outcomes include feasibility metrics (recruitment, retention, adherence, fidelity, adverse events) and acceptability ratings from adolescents, parents, and therapists. Secondary outcomes include changes in suicidal ideation, suicidal behavior, shame, and coping styles, assessed at baseline, post-treatment, and 1-, 3-, and 6-month follow-ups.
Findings will inform refinement of the intervention manual, establish feasibility benchmarks, and provide effect size estimates to guide a subsequent large-scale RCT.
Eligibility criteria
Qualifiers
Adolescents aged 13-18 years, male or female.
Elevated shame level (baseline score ≥ 9 on the External and Internal Shame Scale, EISS).
Adequate cognitive capacity to participate in interviews and assessments.
Parent/legal guardian (or designated responsible adult authorized by guardian) provides informed consent and agrees to participate.
Disqualifiers
Current manic episode.
History of schizophrenia spectrum disorder, intellectual disability, or organic brain disease.
Severe psychiatric or medical conditions that impair capacity for consent or participation.
Expected to receive electroconvulsive therapy (ECT) during hospitalization.
Trial design
Treatments tested in this trial
- Shame-Focused Cognitive Behavioral Therapy (SF-CBT)
- Supportive Therapy (ST)
Treatment groups
42 Participants
are divided into 2 treatment groupsSponsors and collaborators
Peking University
Lead sponsor
Peking University Sixth Hospital
Collaborator
Source ClinicalTrials.gov